bioMérieux Stock Euronext Paris
Equities
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.9B 4.2B | Sales 2025 * | 4.19B 4.51B | Capitalization | 11.75B 12.64B |
---|---|---|---|---|---|
Net income 2024 * | 467M 502M | Net income 2025 * | 527M 567M | EV / Sales 2024 * | 2.94 x |
Net cash position 2024 * | 263M 283M | Net cash position 2025 * | 444M 477M | EV / Sales 2025 * | 2.7 x |
P/E ratio 2024 * |
25.8
x | P/E ratio 2025 * |
22.8
x | Employees | - |
Yield 2024 * |
0.87% | Yield 2025 * |
1.01% | Free-Float | 36.21% |
Latest transcript on bioMérieux
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 16-10-31 |
Chairman | 50 | 04-04-15 | |
Director of Finance/CFO | 47 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 06-09-14 | |
Director/Board Member | 63 | 04-12-31 | |
Chairman | 50 | 04-04-15 |
1st Jan change | Capi. | |
---|---|---|
-6.06% | 8.01B | |
-0.47% | 5.35B | |
+21.79% | 5.23B | |
+2.05% | 4.69B | |
-51.30% | 3.26B | |
+7.80% | 2.64B | |
-7.55% | 2.23B | |
-0.96% | 1.94B | |
+6.50% | 1.66B |